Skip to content
A5721Assembly2021-2022 Session

Stop Drug Price Gouging

Official title

“Relates to the price gouging of pharmaceuticals”

Status
In Assembly Committee
Consumer Affairs And Protection
Impact
7/10
Significant
Passage
0%

Bill progress

Step 2 of 7

In committee · Consumer Affairs And Protection

What's happening

This bill prohibits pharmaceutical manufacturers and wholesalers from price gouging and allows courts to impose penalties for excessive pricing.

Why it matters

  1. Establishes a legal standard for “unconscionably excessive” drug prices. , giving courts the authority to decide what counts as excessive based on clear factors like the degree of price increase and whether unfair leverage was used. This creates a more concrete framework for challenging high drug prices.

  2. Requires evidence of gross price disparities. , such as a steep increase compared to recent historical prices or prices much higher than those paid by other purchasers. This gives consumers and the state a pathway to challenge sudden or unjustified price hikes.

  3. Allows pharmaceutical companies to defend themselves. by showing that higher prices are due to costs outside their control, providing some balance and acknowledging legitimate market changes or supply chain issues.

  4. Empowers the state attorney general to seek court orders and significant penalties. (up to $1 million per violation) and restitution for consumers, which could deter price gouging and provide direct relief for those harmed by excessive pharmaceutical prices.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Stop Drug Price Gouging

Plain English, a few words. Used as the page title.

Sponsors

History

  1. Referred to consumer affairs and protection
  2. Referred to consumer affairs and protection

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

5721

2021-2022 Regular Sessions

IN ASSEMBLY

February 24, 2021

Introduced by M. of A. SIMON -- read once and referred to the Committee on Consumer Affairs and Protection

AN ACT to amend the general business law, in relation to the price gouging of pharmaceuticals

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. The general business law is amended by adding a new section 396-rrr to read as follows:

§ 396-rrr. Price gouging; pharmaceuticals. 1. For the purposes of this section, "pharmaceuticals" shall mean any compound manufactured for sale as a medicinal drug.

2. No manufacturer or wholesaler of pharmaceuticals shall sell or offer to sell pharmaceuticals for an amount which represents an unconscionably excessive price. Whether a price is unconscionably excessive is a question of law for the court.

3. The court's determination that a violation of this section has occurred shall be based on any of the following factors:

(a) that the amount of the excess in price is unconscionably extreme;

(b) that there was an exercise of unfair leverage or unconscionable means; or

(c) a combination of both factors.

4. In any court proceeding commenced pursuant to this section, proof that a violation of this section has occurred shall include evidence that:

(a) the amount charged represents a gross disparity between the market price of the pharmaceutical that led to the action under this section and the price of the same pharmaceutical over the six months prior to the price change that led to the action under this section; or

(b) the amount charged grossly exceeded the price at which the pharmaceuticals were readily obtainable by other purchasers.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD09487-01-1

A. 5721 2

5. A defendant may rebut a prima facie case with evidence that additional costs not within the control of the defendant were imposed on the defendant.

6. Where a violation of this section is alleged to have occurred, the attorney general may apply in the name of the people of the state of New York to the supreme court within the judicial district in which such violation is alleged to have occurred, on notice of five days, for an order enjoining or restraining commission or continuance of the alleged unlawful acts. In any such proceeding where a violation is found to have occurred, the court shall impose a civil penalty in an amount not to exceed one million dollars and, where appropriate, order restitution to aggrieved consumers.

§ 2. This act shall take effect immediately.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.